Thyrocare Technologies (THYROCARE) — Buyback / Redemption

📢 Key Event
Pledge released after full redemption of INR 1,700 crore NCDs

🔄 What Changed
Release of pledge over equity shares following complete discharge of NCD obligations

💡 Investor Takeaway
The removal of the pledge eliminates a key security risk and improves the company's capital structure clarity for investors.

Thyrocare announced that the pledge securing its non-convertible debentures issued by API Holdings was fully released after complete redemption and repayment of the INR 1,700 crore NCDs. The Debenture Trustee issued a No-Dues and Release Certificate on August 19, 2026, confirming discharge of all obligations under the transaction documents. This eliminates the earlier security interest over equity shares held by Docon Technologies Private Limited.

📄 View Original Announcement (PDF)

📊 Stock Analysis — THYROCARE ✨ Ask AI About This

About Thyrocare Technologies Limited (THYROCARE)

Healthcare · Healthcare · Listed on NSE

Market Cap: ₹9,402.69 Cr P/E: 34.6 ROE: 34.3% ROCE: 45.6% Div Yield: 1.18%

View full THYROCARE stock details →

📡 Get AI alerts when THYROCARE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track THYROCARE — Free

💡 Ask AI about this filing

"What is the current shareholding pattern after the pledge release?" "How does this affect Thyrocare's debt-to-equity ratio?" "Are there any remaining contingent liabilities tied to the NCDs?"

Ask AI Free →

📊 More THYROCARE filings

See all THYROCARE filings →

🔥 Also filed on 19 August 2026

GOCOLORS Go Fashion (India) Limited Annual Report OIL Oil India Limited Corporate Action GLAXO GlaxoSmithKline Pharmaceuticals Limited Financial Results TIL TIL Limited Financial Results SETUINFRA Setubandhan Infrastructure Limited Financial Results ASALCBR Associated Alcohols & Breweries Ltd. Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when THYROCARE files new disclosures

Track THYROCARE filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track THYROCARE — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd